RBOT Stock Analysis: Buy, Sell, or Hold?
RBOT - Vicarious Surgical Inc.
$2.24
0.15 (7.18%)
▲
5d:
-3.45%
30d:
-11.11%
90d:
-57.97%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 16, 2026
Get Alerted When RBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RBOT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RBOT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RBOT is currently trading at $2.24, which is considered slightly low relative to its 30-day fair value range of $2.12 to $2.69.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $2.02, while resistance sits at $2.75. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: RBOT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+139.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $2.02, while resistance sits at $2.75. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: RBOT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+139.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$2.12 -
$2.69
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.2%)
- BULLISH: Trading 139.2% below Wall St target ($5.00)
Fair Price Analysis
30-Day Fair Range
$2.12 -
$2.69
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.02
Resistance Level
$2.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.51
Wall Street Target
$5.00
(+139.2%)
Last updated: February 03, 2026 10:06 AM ET
Data refreshes hourly during market hours. Next update: 11:06 AM
Data refreshes hourly during market hours. Next update: 11:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Sammy Khalifa
SELL
239 shares
2025-09-03
Adam David Sachs
SELL
463 shares
2025-09-03
Donald F Tang
SELL
2753 shares
2025-08-26
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 69 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 57 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
